GH Research PLC has a consensus price target of $41.8 based on the ratings of 5 analysts. The high is $66 issued by Roth Capital on June 16, 2022. The low is $31 issued by Canaccord Genuity on May 6, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Canaccord Genuity, and HC Wainwright & Co. on May 7, 2024, May 6, 2024, and March 4, 2024, respectively. With an average price target of $37 between HC Wainwright & Co., Canaccord Genuity, and HC Wainwright & Co., there's an implied 217.32% upside for GH Research PLC from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/07/2024 | Buy Now | 243.05% | HC Wainwright & Co. | Patrick Trucchio | → $40 | Reiterates | Buy → Buy | Get Alert |
05/06/2024 | Buy Now | 165.87% | Canaccord Genuity | Sumant Kulkarni | $30 → $31 | Maintains | Buy | Get Alert |
03/04/2024 | Buy Now | 243.05% | HC Wainwright & Co. | Patrick Trucchio | → $40 | Reiterates | Buy → Buy | Get Alert |
03/01/2024 | Buy Now | 234.48% | JMP Securities | Jason Butler | $50 → $39 | Maintains | Market Outperform | Get Alert |
01/18/2024 | Buy Now | 243.05% | HC Wainwright & Co. | Patrick Trucchio | → $40 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | Buy Now | 243.05% | HC Wainwright & Co. | Patrick Trucchio | $45 → $40 | Maintains | Buy | Get Alert |
07/06/2023 | Buy Now | 285.93% | HC Wainwright & Co. | Patrick Trucchio | → $45 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 285.93% | HC Wainwright & Co. | Patrick Trucchio | → $45 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 320.24% | JMP Securities | Jason Butler | $46 → $49 | Maintains | Outperform | Get Alert |
03/13/2023 | Buy Now | 285.93% | HC Wainwright & Co. | Patrick Trucchio | → $45 | Reiterates | → Buy | Get Alert |
03/02/2023 | Buy Now | 183.02% | EF Hutton | Elemer Piros | → $33 | Reiterates | → Buy | Get Alert |
12/16/2022 | Buy Now | 183.02% | EF Hutton | Elemer Piros | → $33 | Initiates | → Buy | Get Alert |
08/16/2022 | Buy Now | 285.93% | HC Wainwright & Co. | Patrick Trucchio | → $45 | Initiates | → Buy | Get Alert |
06/16/2022 | Buy Now | 466.04% | Roth Capital | Elemer Piros | → $66 | Initiates | → Buy | Get Alert |
04/13/2022 | Buy Now | 251.63% | Canaccord Genuity | Sumant Kulkarni | $45 → $41 | Maintains | Buy | Get Alert |
The latest price target for GH Research (NASDAQ:GHRS) was reported by HC Wainwright & Co. on May 7, 2024. The analyst firm set a price target for $40.00 expecting GHRS to rise to within 12 months (a possible 243.05% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for GH Research (NASDAQ:GHRS) was provided by HC Wainwright & Co., and GH Research reiterated their buy rating.
There is no last upgrade for GH Research
There is no last downgrade for GH Research.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GH Research, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GH Research was filed on May 7, 2024 so you should expect the next rating to be made available sometime around May 7, 2025.
While ratings are subjective and will change, the latest GH Research (GHRS) rating was a reiterated with a price target of $40.00 to $40.00. The current price GH Research (GHRS) is trading at is $11.66, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.